モリヤ タクヤ
Takuya Moriya
森谷 卓也 所属 川崎医科大学 医学部 臨床医学 病理学 職種 教授 |
|
論文種別 | 症例報告 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | [A Case Report of Surgery and Chemotherapy for a Patient with Rapidly Progressing Breast Cancer during Pregnancy]. |
掲載誌名 | 正式名:Gan to kagaku ryoho. Cancer & chemotherapy 略 称:Gan To Kagaku Ryoho ISSNコード:03850684/03850684 |
掲載区分 | 国外 |
巻・号・頁 | 45(5),pp.847-850 |
著者・共著者 | Hazama Yukiko, Nakai Yuichiro, Sugawara Shiori, Nomura Tsunehisa, Matsumoto Keiko, Matsumoto Ryou, Sugihara Mika, Ishida Tsuyoshi, Murata Susumu, Murata Takuya, Nakamura Takafumi, Moriya Takuya, Kurebayashi Junichi, Shimoya Koichiro |
発行年月 | 2018/05 |
概要 | A 33-year-old woman became aware of a right breast mass at her 28th week of pregnancy. From the biopsy results, we diagnosed her with right breast cancer. At her 33rd week of pregnancy, she underwent modified radical mastectomy (pT2N3aM0, Stage III C, ER-negative, PR-negative, HER2-positive), and she elected to receive adjuvant therapy after the surgery during her pregnancy. She received the first course of EC (epirubicin plus cyclophosphamide) therapy on the 13th postoperative day (35 weeks of gestation) and gave a natural, vaginal delivery at 36 weeks and 5 days of gestation. On the 4th day after birth, the patient noticed a contralateral left breast mass and was diagnosed with left breast cancer, after core needle biopsy. She received 4 courses of EC therapy and is currently undergoing PTX plus HER (paclitaxel plus trastuzumab) therapy. Regarding chemotherapy during pregnancy, we recommend that there is no need to perform artificial preterm birth, because chemotherapy has little influence on children after their second-trimester. After the second-trimester, chemotherapy can be safely performed. |
PMID | 30026449 |